1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
Follow Azithromycin 250 mg: new trials by email Literature Review of Azithromycin 250 mg trials Research Report on Azithromycin 250 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Effectiveness of Roflumilast and Azithromycin in Reducing Exacerbations in Severe Chronic Obstructive Pulmonary Disease ( COPD ) Patients With Chronic Bronchitis Phenotype Roflumilast Oral Tablet, Azithromycin 250 mg - Chronic Obstructive Pulmonary Disease With Exacerbation | Phase 4 | Not yet recruiting | Sidra Aziz | 70 | 2027-02-01 | 2026-08-31 |
| Azithromycin to Modify Bronchiectasis Exacerbation Risk Standard Bronchiectasis Care, Azithromycin, Matching Placebo - Non-cystic Fibrosis Bronchiectasis, Bronchiectasis Adult | Phase 4 | Recruiting | Assiut University | 500 | 2026-06-29 | 2026-09-24 |
| AZISAST Study: AZIthromycin in Severe ASThma Study Azithromycin 250 mg, Placebo - Asthma | Phase 4 | Completed | University Hospital, Ghent | 109 | 2009-03-01 | 2014-06-26 |
Asthma (1) · Bronchiectasis (1) · Pulmonary Disease, Chronic Obstructive (1)
Assiut University (1) · Sidra Aziz (1) · University Hospital, Ghent (1)
Belgium (1) · Egypt (1)
Ahmad M. Shaddad, MD (1) · Alaa S. Ali (1) · Aliae M. Hussien, MD (1) · Guy Brusselle, MD, PhD (1) · Maiada K. Hashem, MD (1)